Featured
Want to learn more about Cardiovascular Safety and Development of Type 2 Diabetes Mellitus Medications: Current State of the Art and Opportunities to Advance the Science? You've come to the right site!
プログラム委員会
-
Philip T. Sager, MD Adjunct Professor
Stanford University, United States -
Boaz Mendzelevski, MD Consultant Cardiologist
Cardiac Safety Consultants Ltd., United Kingdom -
Börje C. Darpö, MD, PHD Chief Scientific Officer, Cardiac Safety
Clario, Sweden -
Mary Parks, MD Director, Div. of Endocrinology and Metabolism Prod., ODE II, CDER
FDA, United States -
Norman Stockbridge, MD, PHD Director, Division of Cardiology and Nephrology, OND, CDER
FDA, United States
